Old Web
English
Sign In
Acemap
>
authorDetail
>
Ekaterina Ovsiannikova
Ekaterina Ovsiannikova
Immunology
Medicine
Internal medicine
Oncology
Myeloid leukemia
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Aza Maintenance After Consolidation Increase RFS in Mrdve+ Low Risk AML Patients
2019
Clinical Lymphoma, Myeloma & Leukemia
Larisa Girshova
Irina Budaeva
Daniil Zaicev
Ekaterina Ovsiannikova
Renat Badaev
Tatjana Nikulina
Konstantin Bogdanov
Julia Mirolubova
Dmitrij Motorin
Julia Alexeeva
Andrey Zaritskey
Show All
Source
Cite
Save
Citations (0)
Early Reduction of WT1 Transcript Level During Induction Chemotherapy Predicts for Longer Relapse-Free and Overall Survival in De Novo Intermediate Risk Acute Myeloid Leukemia
2018
Clinical Lymphoma, Myeloma & Leukemia
Larisa Girsova
Irina Budaeva
Rinat Badaev
Konstantin Bogdanov
Tatjana Nikulina
Julia Mirolubova
Ekaterina Ovsiannikova
Dmitriy Motorin
Andrey Zaritskey
Show All
Source
Cite
Save
Citations (0)
MRD Level in NPM1 Mutated and RUNX1-RUNX1T1 Positive AML Predicts RFS and Defines Indications for ASCT
2017
Clinical Lymphoma, Myeloma & Leukemia
Larisa Girshova
Irina Budaeva
So Kuzin
Ekaterina Ovsiannikova
Konstantin Bogdanov
Tatjana Nikulina
Julia Mirolyubova
Dmitriy Motorin
Andrey Zaritskey
Show All
Source
Cite
Save
Citations (0)
1